| Outgoing Relation(s) |
| β-adrenergic antagonist (CHEBI:35530) is a adrenergic antagonist (CHEBI:37887) |
| β-adrenergic antagonist (CHEBI:35530) is a β-adrenergic drug (CHEBI:48540) |
| Incoming Relation(s) |
| (S)-timolol (anhydrous) (CHEBI:9599) has role β-adrenergic antagonist (CHEBI:35530) |
| (S)-timolol hemihydrate (CHEBI:60787) has role β-adrenergic antagonist (CHEBI:35530) |
| (S)-timolol maleate (CHEBI:9600) has role β-adrenergic antagonist (CHEBI:35530) |
| (2R,3S,2'R)-nadolol (CHEBI:60917) has role β-adrenergic antagonist (CHEBI:35530) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role β-adrenergic antagonist (CHEBI:35530) |
| 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine (CHEBI:52450) has role β-adrenergic antagonist (CHEBI:35530) |
| acebutolol (CHEBI:2379) has role β-adrenergic antagonist (CHEBI:35530) |
| acebutolol hydrochloride (CHEBI:2380) has role β-adrenergic antagonist (CHEBI:35530) |
| alprenolol (CHEBI:51211) has role β-adrenergic antagonist (CHEBI:35530) |
| asenapine (CHEBI:71253) has role β-adrenergic antagonist (CHEBI:35530) |
| asenapine maleate (CHEBI:71245) has role β-adrenergic antagonist (CHEBI:35530) |
| atenolol (CHEBI:2904) has role β-adrenergic antagonist (CHEBI:35530) |
| betaxolol (CHEBI:3082) has role β-adrenergic antagonist (CHEBI:35530) |
| betaxolol hydrochloride (CHEBI:643228) has role β-adrenergic antagonist (CHEBI:35530) |
| bevantolol (CHEBI:238698) has role β-adrenergic antagonist (CHEBI:35530) |
| bevantolol hydrochloride (CHEBI:31282) has role β-adrenergic antagonist (CHEBI:35530) |
| bisoprolol (CHEBI:3127) has role β-adrenergic antagonist (CHEBI:35530) |
| bopindolol (CHEBI:76749) has role β-adrenergic antagonist (CHEBI:35530) |
| Byvalson (CHEBI:132911) has role β-adrenergic antagonist (CHEBI:35530) |
| carteolol (CHEBI:3437) has role β-adrenergic antagonist (CHEBI:35530) |
| carteolol hydrochloride (CHEBI:3438) has role β-adrenergic antagonist (CHEBI:35530) |
| carvedilol (CHEBI:3441) has role β-adrenergic antagonist (CHEBI:35530) |
| CGP 12177 (CHEBI:73288) has role β-adrenergic antagonist (CHEBI:35530) |
| esatenolol (CHEBI:31556) has role β-adrenergic antagonist (CHEBI:35530) |
| esmolol (CHEBI:4856) has role β-adrenergic antagonist (CHEBI:35530) |
| esmolol hydrochloride (CHEBI:4857) has role β-adrenergic antagonist (CHEBI:35530) |
| icatibant (CHEBI:68556) has role β-adrenergic antagonist (CHEBI:35530) |
| icatibant acetate (CHEBI:68564) has role β-adrenergic antagonist (CHEBI:35530) |
| ICI 118551 (CHEBI:73289) has role β-adrenergic antagonist (CHEBI:35530) |
| iodocyanopindolol (CHEBI:73370) has role β-adrenergic antagonist (CHEBI:35530) |
| labetalol (CHEBI:6343) has role β-adrenergic antagonist (CHEBI:35530) |
| levobunolol (CHEBI:6438) has role β-adrenergic antagonist (CHEBI:35530) |
| levobunolol hydrochloride (CHEBI:6439) has role β-adrenergic antagonist (CHEBI:35530) |
| metipranolol (CHEBI:6897) has role β-adrenergic antagonist (CHEBI:35530) |
| metipranolol hydrochloride (CHEBI:34845) has role β-adrenergic antagonist (CHEBI:35530) |
| metoprolol (CHEBI:6904) has role β-adrenergic antagonist (CHEBI:35530) |
| nadolol (CHEBI:7444) has role β-adrenergic antagonist (CHEBI:35530) |
| nebivolol (CHEBI:64022) has role β-adrenergic antagonist (CHEBI:35530) |
| nebivolol hydrochloride (CHEBI:132912) has role β-adrenergic antagonist (CHEBI:35530) |
| penbutolol sulfate (CHEBI:7955) has role β-adrenergic antagonist (CHEBI:35530) |
| pindolol (CHEBI:8214) has role β-adrenergic antagonist (CHEBI:35530) |
| PP2 (CHEBI:78331) has role β-adrenergic antagonist (CHEBI:35530) |
| practolol (CHEBI:258351) has role β-adrenergic antagonist (CHEBI:35530) |
| propranolol (CHEBI:8499) has role β-adrenergic antagonist (CHEBI:35530) |
| sotalol (CHEBI:63622) has role β-adrenergic antagonist (CHEBI:35530) |
| sotalol hydrochloride (CHEBI:9207) has role β-adrenergic antagonist (CHEBI:35530) |
